Lewis Base Ligands Designed to Control Carbon-Carbon Bond Formation
旨在控制碳-碳键形成的路易斯碱配体
基本信息
- 批准号:10713775
- 负责人:
- 金额:$ 36.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAcidsAddressAlkaloidsBindingBiologicalCarbonCatalysisCationsChemistryClinicContraceptive AgentsCouplingDevelopmentEventExhibitsGoalsHydrogen BondingIonsLigandsLinkLocationMedicineNitrogenOrganic ChemistryOrganic SynthesisPesticidesPhosphinesPositioning AttributeProcessPropertyReactionReagentReproductive RightsShapesSocietiesSynthesis ChemistryTherapeuticTransition ElementsWomanWorkbasecatalystdeprotonationdesigndrug discoveryfallsfunctional grouphuman diseaseinnovationinventionoperationoxidationsmall molecule
项目摘要
PROJECT SUMMARY/ABSTRACT:
The impact of synthetic chemistry on society cannot be overstated. Organic chemistry has changed our world
in momentous ways, from giving women reproductive rights through the invention of contraceptives, to creating
pesticides that allow us to feed the globe. It is axiomatic that innovations in medicine are invariably linked to
advancements in organic chemistry as most medicines are synthesized by organic chemists. It has long been
recognized that the overall shape of a small molecule is the most fundamental factor that controls its biological
effects. It is fortunate that rapid developments in asymmetric synthesis have paved the way for therapeutics to
reach the clinic. These triumphs can be attributed to the many innovations in the realms of enantioselective bond
forming processes such as asymmetric ion pairing, organocatalysis, C–H activation, Lewis acid/base, BrØnsted
acid/base, reductions/oxidations, cross-coupling reactions and many more. Despite these achievements, the
state of the art still falls short in many ways from the ideal. Although each of the unique activation modes outlined
above allow for high chemo-, diastero- and enantio-selectivities to be achieved, in many cases for the desired
bond forming event to occur the substrate must often bear a functional group that is capable of binding or being
activated by a chiral catalyst. In particular, the ability to enantioselectively convert inert C–H bonds into carbon-
carbon bonds at specific locations without the aid of directing groups is highly desirable because it would further
the drug discovery process.
To address this challenge, our work has focused on the development of new deprotonation substitution
sequences which allow for typically untargetable positions within heterocycles to be directly functionalized.
Specifically, we have found that Lewis bases can extract Li cations from strong organolithium reagents allowing
highly basic ion pairs to be produced and in turn for typically remote and inert C–H bonds in heterocycles to be
deprotonated. Secondly, we have developed a new class of chiral phosphine ligands that enable
enantioconvergent cross-couplings with racemic donor reagents. This proposal seeks to merge these concepts
by developing asymmetric deprotonation cross-coupling sequences that can allow for typically inaccessible
carbon centers to be functionalized. Specific goals of this proposal include: (1) the development of both
organolithium reagents and Lewis bases that when combined allow for typically inert C–H bonds in alkaloids to
be deprotonated; (2) the development of new chiral phosphine ligands that enable enantioconvergent Negishi
cross-coupling reactions with racemic donor reagents; and (3) the development of asymmetric deprotonation
cross-coupling sequences that allow for biologically relevant alkaloids to be directly functionalized in a single
synthetic operation.
项目摘要/摘要:
合成化学对社会的影响不能被夸大。有机化的化学改变了我们的世界
从赋予避孕药的发明到创造妇女的生殖权利到创造
使我们能够养活全球的农药。医学上的创新与
由于大多数药物是有机化学家合成的,有机化学的进步。长期以来已经
认识到小分子的整体形状是控制其生物学的最基本因素
效果。幸运的是,不对称合成的快速发展为治疗铺平了道路
到达诊所。这些胜利可以归因于对映选择性纽带领域中的许多创新
形成诸如不对称离子配对,有机催化,C – H激活,刘易斯酸/碱,Brønsted等过程
酸/碱,减少/氧化,交叉偶联反应等等。尽管取得了这些成就,
与理想相比,最新的状态在许多方面仍然缺乏。尽管概述了每个唯一激活模式
以上允许在许多情况下实现高化学,映射和对映体选择性
发生的债券形成事件发生的底物通常必须承担能够结合或存在的功能组
被手性催化剂激活。特别是,将惰性C – H键转换为碳的能力
在没有指导群体的情况下,在特定位置的碳键是非常需要的
药物发现过程。
为了应对这一挑战,我们的工作重点是开发新的去质子化替代
允许在杂环中通常不可辨的位置的序列直接功能化。
具体而言,我们发现刘易斯基地可以从较强的有机锂试剂中提取li阳离子,允许
高碱基的离子对要生产,而杂环中通常偏远和惰性C – H键
去质子化。其次,我们开发了一种新的手性磷酸配体,以实现
映体ver剂与消极供体试剂的交叉耦合。该提议试图合并这些概念
通过开发不对称的去质子化交叉耦合序列,该序列通常允许无法访问
碳中心要功能化。该建议的具体目标包括:(1)
有机矿试剂和刘易斯基地,合并后允许在生物碱中惰性C – H键
被质子化; (2)开发新的手性膦配体,使启用negishi启用negishi
与外围供体试剂的交叉偶联反应; (3)不对称去质子化的发展
交叉耦合序列,允许在单个中直接化生物学相关的生物碱
合成操作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andy Alexander Thomas其他文献
Andy Alexander Thomas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andy Alexander Thomas', 18)}}的其他基金
Copper-Catalyzed Enantioselective Addition of Styrene-Derived Nucleophiles to Thiocarbenium Ions by Ligand-Controlled Chemoselective Hydrocupration
通过配体控制的化学选择性加氢反应,铜催化苯乙烯衍生的亲核试剂与硫碳鎓离子的对映选择性加成
- 批准号:
9395476 - 财政年份:2017
- 资助金额:
$ 36.72万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Toward synthetic chemically defined mRNA for human therapeutics
用于人类治疗的合成化学定义的 mRNA
- 批准号:
10649299 - 财政年份:2023
- 资助金额:
$ 36.72万 - 项目类别:
Rapid point-of-care detection of Trichomonas Vaginalis
快速即时检测阴道毛滴虫
- 批准号:
10699836 - 财政年份:2023
- 资助金额:
$ 36.72万 - 项目类别:
Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
- 批准号:
10443241 - 财政年份:2022
- 资助金额:
$ 36.72万 - 项目类别:
Nanostructured surfaces with improved hemocompatibility
具有改善血液相容性的纳米结构表面
- 批准号:
10686166 - 财政年份:2022
- 资助金额:
$ 36.72万 - 项目类别: